Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Crobenetine in Acute Ischemic Stroke
NCT02251197Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2001
- Primary completion
- Oct 2002
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of crobenetine in ischemic stroke, sponsored by Boehringer Ingelheim. Started Jul 2001; status: completed.
02
Drugs
crobenetine
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT02251197.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02251197.